Wu, J., Xu, P. and Zeng, S. (2022) “Trastuzumab therapies in human epidermal growth factor receptor 2 cancer”, Highlights in Science, Engineering and Technology, 8, pp. 32–40. doi:10.54097/hset.v8i.1107.